Sociedad Americana de Hirudoterapia

Symbiont succession during embryonic development of the European medicinal leech, Hirudo verbana

Research article published in Appl Environ Microbiol (2009)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Seguridad y control de infeccionesRio RV et al. · Appl Environ Microbiol, 2009

Abstract

The European medicinal leech, Hirudo verbana, harbors simple microbial communities in the digestive tract and bladder. The colonization history, infection frequency, and growth dynamics of symbionts through host embryogenesis are described using diagnostic PCR and quantitative PCR. Symbiont species displayed diversity in temporal establishment and proliferation through leech development.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
Indexed MeSH termsAnimalsBacteriaBiodiversityDNA, BacterialDNA, RibosomalGastrointestinal TractLeechesPolymerase Chain ReactionRNA, Ribosomal, 16S

Resumen

PCR-based characterization of microbial colonization during Hirudo verbana embryogenesis; symbiont species displayed temporal establishment and proliferation diversity.

Por qué esto importa para la hirudoterapia

This study used diagnostic PCR and quantitative PCR to characterize the colonization history, infection frequency, and growth dynamics of symbiotic bacteria in the digestive tract and bladder of the European medicinal leech (Hirudo verbana) throughout host embryonic development. The authors found that different symbiont species displayed diversity in their timing of establishment and proliferation during leech development. This work is indirectly relevant to ASH's domain because understanding how microbial symbionts colonize medicinal leeches may inform future strategies for managing leech-associated infection risk in hirudotherapy. However, the study is purely descriptive basic biology with no therapeutic, clinical, or infection-control endpoints, and does not address hirudotherapy practice, anticoagulation, or the leech secretome.

Citación

Symbiont succession during embryonic development of the European medicinal leech, Hirudo verbana.

Rio RV et al. · Appl Environ Microbiol, 2009

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.